Key statistics
As of last trade Abivax SA (ABVX:NMQ) traded at 126.06, -15.30% below its 52-week high of 148.83, set on Dec 24, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 126.51 |
|---|---|
| High | 127.95 |
| Low | 123.94 |
| Bid | 125.71 |
| Offer | 126.41 |
| Previous close | 124.99 |
| Average volume | 680.60k |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Feb 17 2026 19:25 GMT.
More ▼
Announcements
- Abivax to be Added to Nasdaq Biotechnology Index
- Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
- Abivax Presents First Half 2025 Financial Results
- Abivax Announces Closing of $747.5 Million Public Offering
- Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)
- Abivax announces trading resumption of its ordinary shares on Euronext Paris
- Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares
- Abivax announces temporary trading halt of its ordinary shares on Euronext Paris
- Abivax Presents First Quarter 2025 Financial Results
- Abivax publishes financial reports with the French and U.S. securities regulatory agencies
More ▼
